When pharmaceutical company Merck & Co. fell victim to the “NotPetya” computer virus in June 2017 and was later denied coverage by its insurance carrier under the policies’ war risk exclusions, the insurers’ outdated policy language turned into a “resounding victory” for Merck.

In a recent article authored by Insurance recovery & Advisory partner Robert Wallan and Litigation counsel John Chamberlain, the two discuss the case, Merck & Co. v. ACE Am. Ins. Co., and how policyholders should carefully scrutinize the scope of coverage—specifically cyber coverage and protection—in the future.

To read the full article, click here.